Back to catalog
FOXO4-DRI
Anti-Aging

FOXO4-DRI

≥98.5% Purity Verified
FOXO4-10MG-B2026
$110.00per 10mg / vial

A D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction, targeted in senolytic research to selectively induce apoptosis in senescent cells while sparing healthy tissue.

Specification10mg / vial
HPLC Purity≥98.5%
Total mg / vial10 mg
SequenceD-Retro-Inverso FOXO4 Fragment
AvailabilityIn Stock (60 units)
Quantity
1

Research Use Only: This product is intended solely for in vitro laboratory research and scientific study. Not for human or veterinary use.

Technical Reference

Product Data Sheet

Identity & Properties
Product NameFOXO4-DRI
FormatSingle Compound
Specification10mg / vial
Total mg / vial10 mg
Physical FormLyophilised powder
AppearanceWhite to off-white powder
Storage−20 °C (long-term)
Shelf Life24–36 months (sealed)
SolubilitySoluble in water / acetic acid
Analytical Data
HPLC Purity≥98.5%
Identity MethodMass Spectrometry (MS)
MS ToleranceΔ < 0.05 Da
Testing LabISO 17025-accredited
Batch CodeFOXO4-10MG-B2026
Synthesis MethodSPPS (Solid-Phase)
Lot TraceabilityFull lot-locked
Handling & Safety

Handle in a controlled laboratory environment with appropriate PPE.

Reconstitute only with sterile bacteriostatic water or acetic acid as appropriate.

Aliquot and store at −20 °C. Avoid repeated freeze-thaw cycles.

Not for human, veterinary, or agricultural use under any circumstances.

Dispose of in accordance with local laboratory waste regulations.

Regulatory Notice

This product is an analytical reference material for in-vitro research only. It has not been evaluated by the FDA or any regulatory authority. Purchase and use must comply with all applicable laws in your jurisdiction.